Abstract
Hepatic progenitor cells (HPCs) are important in liver pathologies and hepatocellular carcinoma (HCC). GCTM-5, a marker of HPCs, is a new candidate prognostic biomarker. The thesis develops a semi-computerised approach using the software "InForm" to quantify the HPC response and assess liver disease severity using custom algorithms. The frequency of GCTM-5+ve cells were associated with necroinflammation in acute hepatitis (r2=0.7362, p-value less than 0.01), and with clinical outcomes in HCC (p-value less than 0.05). This study establishes GCTM-5 as a prognostic biomarker of interest in acute hepatitis and HCC. Further studies are warranted to authenticate its prognostic utility in a large longitudinal cohort.
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Thesis sponsors | |
| Award date | 6 May 2019 |
| DOIs | |
| Publication status | Unpublished - 2019 |
Embargo information
- Embargoed from 06/05/2019 to 06/05/2020. Made publicly available on 06/05/2020.
Access to Document
- THESIS - DOCTOR OF PHILOSOPHY - KRAMER Anne-Sophie - 2019
This work is protected by Copyright. You may print or download ONE copy of this document for the purpose of your own non-commercial research or study. Any other use requires permission from the copyright owner. The Copyright Act requires you to attribute any copyright works you quote or paraphrase.